Jeffrey D. Sachs is a world-renowned economics professor, bestselling author, innovative educator, and global leader in sustainable development. Professor Sachs serves as the Director of the Center for Sustainable Development at Columbia University and is a University Professor, Columbia's highest academic rank.
Steve and Jeffrey discuss:
0:00 Jeffrey Sachs’ experience on the Lancet Commission for COVID-19
13:41 Potential for bioweapons research
19:06 Why a lab leak is plausible
32:38 Possible defenses for COVID coverup
43:56 Government secrecy and other areas of concern
48:08 Reflections on Nord Stream sabotage
The Lancet Commission on lessons for the future from the COVID-19 pandemic, Sachs et al., Sept. 14 2022
Why the Chair of the Lancet’s COVID-19 Commission Thinks The US Government Is Preventing a Real Investigation Into the Pandemic, Current Affairs, Aug 3 2022
My brief summary:
Sachs led a 2 year study of COVID-19 organized for the Lancet. One of the task forces was focused on COVID-19 origins. Sachs feels that members of this task force were engaged in a deliberate cover up which tried to push the natural origin hypothesis from the beginning. His conclusion is that a lab origin hypothesis is still viable, and indeed more likely than the natural origin hypothesis.
The US is treaty bound to only do "defensive" bioweapons research and development, but this includes the creation and study of dangerous viral strains -- e.g., so that vaccine efficacy and related technologies can be studied. As far as I can tell the US spends ~$10 billion per annum on biodefense research, much of it funneled through NIAID (NIH institute for infectious diseases). Many of the researchers involved in "gain of function" genetic engineering are funded via NIAID and have been for decades. Sachs claims that the genetic engineering research to add a human-specific cleavage site to a coronavirus was actually performed, although the specific 2017 DEFUSE research plan (uncovered in 2021 investigation) was not funded.